Pfizer Inc. (PFE)
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Starboard seeks probe after former Pfizer execs pull support for its campaign
Starboard Value has asked Pfizer to set up a special committee to investigate allegations that two of its former senior executives were forced to publicly declare support for CEO Albert Bourla, the hedge fund said on Thursday.
Pfizer Skids After Former Execs Flip On Activist Investor, Siding With CEO Albert Bourla
Pfizer stock skidded Thursday after former executives Ian Read and Frank D'Amelio sided with the drugmaker over activist investor Starboard.
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says
Activist Starboard Value accused Pfizer of threatening litigation against two renegade former executives that initially were supportive of the investor's turnaround campaign at the pharmaceutical giant. Starboard's Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as "flagrantly unethical.
Pfizer's stock dips after two former execs say they won't support Starboard, offer backing for CEO Albert Bourla
Pfizer Inc.'s stock dipped early Thursday, after two of its former executives said they would not support an effort by activist shareholder Starboard Value to orchestrate a turnaround.
Pfizer's cancer drug combo improves overall survival in late-stage study
Pfizer said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of advanced prostate cancer in a late-stage study.
2 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Both of these stocks should have plenty of room to run.
Former Pfizer executives not involved in Starboard's campaign against drugmaker
Pfizer's former CEO and Chair Ian Read and ex-CFO Frank D'Amelio said in a statement that they will not be involved with activist investor Starboard Value, which wants the U.S. drug giant to make changes to turn its performance around.
Former Pfizer CEO, finance chief step back from Starboard's activist campaign
Two former Pfizer executives who were previously linked to activist investor Starboard Value's campaign at the struggling drugmaker said they would step back from the push late Wednesday evening. Former CEO Ian Read and ex-CFO Frank D'Amelio voiced their full support for current CEO Albert Bourla and the management team.
Why Pfizer Stock Popped Today
The sharp, sudden entry of an activist investor is raising hopes that change might come to the company.
Pfizer (PFE) Surges Amid Investor Talks and Legal Victory
Pfizer (PFE, Financial) experienced a 2.3% increase, reaching $29.85. The rise follows news that Pfizer's CEO plans to meet next week with key leaders from activist investor Starboard Value.
Pfizer: Investor Activism Is Not The Solution
The story of activist fund Starboard Value taking a $1 billion position in Pfizer is grabbing headlines the last few days. However, no good new solutions are being offered, at least according to the stories and articles that have surfaced since the stake was first mentioned. Additional cost cutting, more share repurchases, or management and board changes are unlikely to make a change for the better at Pfizer.
